Global X - Genomics & Bio... (GNOM)
NASDAQ: GNOM
· Real-Time Price · USD
7.74
0.21 (2.86%)
At close: May 16, 2025, 3:59 PM
7.89
2.00%
After-hours: May 16, 2025, 04:58 PM EDT
2.86% (1D)
| Bid | 7.25 |
| Market Cap | 48.95M |
| AUM | 39.84M |
| NAV | 7.54 |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | n/a |
| Shares Out | 6.33M |
| Inception Date | Apr 4, 2019 |
| Ask | 9.39 |
| Volume | 36.02K |
| Open | 7.53 |
| Previous Close | 7.53 |
| Day's Range | 7.54 - 7.74 |
| 52-Week Range | 6.80 - 11.88 |
| Holdings | 49 |
| Expense Ratio | 0.50% |
About GNOM
The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.
Asset Class Equity
Ticker Symbol GNOM
Inception Date Apr 4, 2019
Provider Global X
Website Fund Home Page
Exchange NASDAQ
Top 10 Holdings 43.08% of assets
| Name | Symbol | Weight |
|---|---|---|
| Alnylam Pharmaceutic... | ALNY | 4.74% |
| Illumina, Inc. | ILMN | 4.53% |
| Bio-techne Corporati... | TECH | 4.42% |
| Natera, Inc. | NTRA | 4.41% |
| Qiagen N.v. | QGEN | 4.28% |
| Avidity Biosciences,... | RNA | 4.19% |
| Crispr Therapeutics ... | CRSP | 4.15% |
| Biomarin Pharmaceuti... | BMRN | 4.15% |
| Moderna, Inc. | MRNA | 4.13% |
| Ultragenyx Pharmaceu... | RARE | 4.08% |
Dividends Dividend Yield 0.03%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Dec 30, 2021 | $0.0065 | Jan 7, 2022 |
| Dec 30, 2020 | $0.0324 | Jan 8, 2021 |
